In this Managed Healthcare Executive Between the Lines video series, Estay Greene, Pharm.D., MBA, and Victoria Bouhairie, M.D ...
The US Food and Drug Administration (FDA) issued a safety communication Friday to warn about adverse event risks in patients’ use of diabetes management devices lacking approvals or clearances. The ...
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery systems ...
NEW YORK, Aug. 1, 2024 /PRNewswire/ -- The global digital diabetes management market size is estimated to grow by USD 19.12 billion from 2024-2028, according to Technavio. The market is estimated to ...
The China Diabetes Devices Market is projected to grow from USD 7.19 billion in 2025 to USD 14.51 billion by 2034, marking a ...
Share on Pinterest MIT engineers have developed a small implantable device that could help people with type 1 diabetes monitor their glucose levels. RichLegg/Getty Images Engineers at MIT say they ...
Australia: A clinical feasibility study published in the Journal of Diabetes Science and Technology has found that an ...
Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...
CDRH Issues Final Orders on Medical Devices for Insulin Adjustment, Drug Screening The Center for Devices and Radiological Health (CDRH) at the US Food and Drug Administration (FDA) issued two final ...
The U.S. Food and Drug Administration (FDA) has classified a recall of Insulet Corporation's PODD Omnipod 5 Pods as its most ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results